Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05GGD
|
|||
| Former ID |
DNCL003752
|
|||
| Drug Name |
SYNVISC-ONE
|
|||
| Indication | Pain [ICD-11: MG30-MG3Z] | Phase 4 | [1] | |
| Company |
Sanofi
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02389452) Study of Safety and Efficacy of 6 mL Synvisc-One (Hylan G-F 20) in Indian Patients With Symptomatic Osteoarthritis of Knee(s) After Initial and Repeat Treatment. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.